"Life sciences work – across transactions, intellectual property and regulatory matters – provided a bright spot in Big Law business in 2020 that firms expect to fuel an even more promising 2021."
Read the article (subscription required)
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
